These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6813555)

  • 1. [Pharmacologic evaluation of electrical processes in the myocardium].
    Sekeresh L
    Kardiologiia; 1982 Aug; 22(8):97-103. PubMed ID: 6813555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacological evaluation of electrical events in the myocardium.
    Szekeres L
    Adv Myocardiol; 1982; 3():223-33. PubMed ID: 6302767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of antiarrhythmic drugs in experimental pharmacology.
    Caillard CG; Louis JC
    Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):223-52. PubMed ID: 6765586
    [No Abstract]   [Full Text] [Related]  

  • 4. [Electrophysiological study of the cardiotropic action of phenothiazine-derivative anti-arrhythmia preparations].
    Shugushev KhKh; Rozenshtraukh LV; Portnoĭ VF; Dvortsin GF; Iushmanova AV
    Kardiologiia; 1986 Nov; 26(11):36-40. PubMed ID: 3543459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Comparison of the effects of mexiletine, lignocaine and procainamide on canine Purkinje fibres.
    Allen JD; Arnold JM
    J Physiol; 1974 Jan; 236(1):26P-28P. PubMed ID: 4818502
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of a combination of N-propylajmaline bromide and trimecaine on heart arrhythmias of different origins and on the electrophysiological parameters of the myocardium].
    Gendenshteĭn EI; Balashov VP; Sosunov EA; Kostin IaV; Oleĭnikov VE
    Farmakol Toksikol; 1991; 54(4):30-3. PubMed ID: 1786818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
    Dupuis BA; Vincent AC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pertinence of animal and human models in the evaluation of ventricular anti-arrhythmia agents].
    Funck-Brentano C; Le Heuzey JY
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():15-20. PubMed ID: 1726994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electrophysiological experimental study of a novel class III antiarrhythmic drug RG-2].
    Rozenshtraukh LV; Fedorov VV; Reznik AV; Sharifov OF; Beloshapko GG; Iushmanova AV; Golitsyn SP; Ruda MIa; Chazov EI
    Kardiologiia; 2003; 43(9):56-63. PubMed ID: 14593371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studying the mechanism of antiarrhythmic action of a tertiary derivative of lidocaine].
    Blinov DS; Kostin IaV; Skachilova SIa
    Eksp Klin Farmakol; 2004; 67(3):18-20. PubMed ID: 15341061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The auricular tissue specialized for conduction: its importance in physiology and antiarrhythmic pharmacotherapy].
    Pastelin G; Cuevas B; Alvarado JL; Méndez R
    Gac Med Mex; 1984; 120(11-12):371-85. PubMed ID: 6152584
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
    Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV
    Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental study on the electrophysiological effects of the combination of the antiarrhythmic drugs aprindine and verapamil.
    Okishige K; Ohtomo K; Satoh T; Hiejima K
    Arch Int Pharmacodyn Ther; 1991; 314():44-56. PubMed ID: 1824189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lidocaine does not affect myocardial electrical heterogeneity: implications for low proarrhythmic actions.
    Sims JJ; Winecoff AP; Ujhelyi MR
    Pharmacotherapy; 1997; 17(6):1267-73. PubMed ID: 9399610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of the antiarrhythmic action of verapamil.
    Sugiyama S; Kitazawa M; Kotaka K; Miyazaki Y; Ozawa T
    J Cardiovasc Pharmacol; 1981; 3(4):801-6. PubMed ID: 6167809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New directions in the development of antiarrhythmic drugs.
    Miura DS; Rosen MR
    J Clin Pharmacol; 1984 Jul; 24(7):333-41. PubMed ID: 6090508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiloride. Antiarrhythmic and electrophysiological activity in the dog.
    Duff HJ; Lester WM; Rahmberg M
    Circulation; 1988 Dec; 78(6):1469-77. PubMed ID: 3191600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
    Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
    Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.